Display options
Share it on

Chem Sci. 2015 Jul 15;6(7):3692-3696. doi: 10.1039/c5sc00228a. Epub 2015 Mar 10.

A general approach to the design of allosteric, transcription factor-regulated DNAzymes.

Chemical science

G Adornetto, A Porchetta, G Palleschi, K W Plaxco, F Ricci

Affiliations

  1. Dipartimento di Scienze e Tecnologie Chimiche University of Rome Tor Vergata , Via della Ricerca Scientifica , Rome 00133 , Italy . Email: [email protected].
  2. Consorzio Interuniversitario Biostrutture e Biosistemi "INBB" , Rome 00136 , Italy.
  3. Department of Chemistry and Biochemistry , University of California Santa Barbara , Santa Barbara , California 93106 , USA.
  4. Center for Bioengineering , University of California Santa Barbara , Santa Barbara , California 93106 , USA.

PMID: 28706715 PMCID: PMC5496187 DOI: 10.1039/c5sc00228a

Abstract

Here we explore a general strategy for the rational design of nucleic acid catalysts that can be allosterically activated by specific nucleic-acid binding proteins. To demonstrate this we have combined a catalytic DNAzyme sequence and the consensus sequence recognized by specific transcription factors to create a construct exhibiting two low-energy conformations: a more stable conformation lacking catalytic activity and lacking the transcription factor binding site, and a less stable conformation that is both catalytically active and competent to bind the transcription factor. The presence of the target transcription factor pushes the equilibrium between these states towards the latter conformation, concomitantly activating catalysis. To demonstrate this we have designed and characterized two peroxidase-like DNAzymes whose activities are triggered upon binding either TATA binding protein or the microphthalmia-associated transcription factor. Our approach augments the current tool kit for the allosteric control of DNAzymes and ribozymes and, because transcription factors control many key biological functions, could have important clinical and diagnostic applications.

References

  1. Nat Methods. 2014 Nov;11(11):1154-60 - PubMed
  2. Clin Chim Acta. 2006 May;367(1-2):20-7 - PubMed
  3. Curr Opin Struct Biol. 2000 Jun;10(3):318-25 - PubMed
  4. Angew Chem Int Ed Engl. 2008;47(14):2604-7 - PubMed
  5. Chem Commun (Camb). 2008 Aug 21;(31):3654-6 - PubMed
  6. Nature. 2011 Oct 19;480(7375):94-8 - PubMed
  7. J Am Chem Soc. 2004 Jun 23;126(24):7430-1 - PubMed
  8. Proc Natl Acad Sci U S A. 2000 May 23;97(11):5784-9 - PubMed
  9. Chem Biol. 1994 Dec;1(4):223-9 - PubMed
  10. Trends Biotechnol. 1994 Jul;12(7):268-75 - PubMed
  11. Chem Rev. 2007 Sep;107(9):3715-43 - PubMed
  12. Pigment Cell Melanoma Res. 2014 Jan;27(1):7-8 - PubMed
  13. J Mol Biol. 2002 Apr 19;318(1):33-43 - PubMed
  14. Nat Chem Biol. 2011 Jul 18;7(8):519-27 - PubMed
  15. Nucleic Acids Res. 2002 Apr 15;30(8):1735-42 - PubMed
  16. Chem Biol. 1998 Jan;5(1):23-34 - PubMed
  17. Cell. 2012 Aug 3;150(3):647-58 - PubMed
  18. Appl Microbiol Biotechnol. 2014 Apr;98(8):3389-99 - PubMed
  19. J Mol Biol. 2000 Jun 16;299(4):965-77 - PubMed
  20. Genes Dev. 1993 Jul;7(7B):1291-308 - PubMed
  21. Curr Opin Struct Biol. 2004 Jun;14(3):283-91 - PubMed
  22. Chem Biol. 1998 Oct;5(10):587-95 - PubMed
  23. Chem Soc Rev. 2008 Jun;37(6):1153-65 - PubMed
  24. Science. 2009 Feb 27;323(5918):1229-32 - PubMed
  25. RNA. 2001 Mar;7(3):395-404 - PubMed
  26. Nat Biotechnol. 2002 Jul;20(7):717-22 - PubMed
  27. J Am Chem Soc. 2011 Sep 7;133(35):13836-9 - PubMed
  28. Curr Opin Mol Ther. 2007 Apr;9(2):132-6 - PubMed
  29. J Am Chem Soc. 2007 Aug 15;129(32):9838-9 - PubMed
  30. Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13802-7 - PubMed
  31. ACS Nano. 2011 Sep 27;5(9):7648-55 - PubMed
  32. Nat Biotechnol. 2009 Mar;27(3):288-92 - PubMed
  33. Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):E554-62 - PubMed
  34. Mol Cell Biol. 1998 Dec;18(12):6930-8 - PubMed
  35. ACS Nano. 2009 Jul 28;3(7):1831-43 - PubMed
  36. J Biol Chem. 2001 Aug 10;276(32):30078-84 - PubMed
  37. Chem Biol. 1997 Jun;4(6):453-9 - PubMed
  38. Cell. 2014 Nov 6;159(4):925-39 - PubMed
  39. Mol Cancer Ther. 2008 Feb;7(2):243-51 - PubMed
  40. Nat Rev Genet. 2010 May;11(5):367-79 - PubMed
  41. PLoS One. 2007 Nov 21;2(11):e1224 - PubMed
  42. Chemistry. 2012 Dec 7;18(50):16030-6 - PubMed
  43. Chem Biol. 1998 Sep;5(9):505-17 - PubMed
  44. ACS Synth Biol. 2015 May 15;4(5):516-25 - PubMed
  45. Cell Mol Life Sci. 2002 Apr;59(4):596-607 - PubMed
  46. J Mol Biol. 2001 Jul 20;310(4):723-34 - PubMed
  47. Anal Chem. 2009 Nov 1;81(21):9114-9 - PubMed
  48. Science. 1995 Feb 3;267(5198):643-7 - PubMed
  49. Anal Chem. 2004 Apr 1;76(7):2152-6 - PubMed
  50. J Am Chem Soc. 2011 Mar 9;133(9):3191-7 - PubMed
  51. Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2056-61 - PubMed
  52. Chemistry. 2014 May 5;20(19):5619-24 - PubMed
  53. Cancer Gene Ther. 2008 Aug;15(8):517-25 - PubMed
  54. Exp Dermatol. 2010 Jul 1;19(7):617-27 - PubMed
  55. Nucleic Acids Res. 2003 Jul 1;31(13):3406-15 - PubMed
  56. Curr Opin Biotechnol. 2002 Feb;13(1):31-9 - PubMed
  57. Chem Biol. 2002 Apr;9(4):417-26 - PubMed
  58. RNA. 1999 Nov;5(11):1482-9 - PubMed
  59. J Am Chem Soc. 2001 Feb 21;123(7):1337-48 - PubMed

Publication Types